Minneapolis , MN – June 19, 2025 – SIME Diagnostics is proud to announce that it has won the Avio and Medtech MVP Pitch Contest, held on Tuesday June 17 in Minneapolis Minnesota. SIME was selected from over 100 high potential startups to pitch as a finalist, ultimately winning the $20,000 dollar top award for its pioneering advancements in AI powered respiratory diagnostics in ICU settings.
The pitch contest brought together some of the most promising minds in Medtech under the banner of “elevating visionary startups shaping the future of healthcare.” A panel of judges composed of investors, hospital executives, and industry leaders praised SIME’s platform for its innovation, clinical relevance, and commercial readiness.
The win follows recent presentations of clinical validation data by Mayo Clinic at the Pediatric Academic Societies (PAS) Conference, further cementing SIME’s position at the cutting edge of neonatal science and medtech innovation.
“This recognition speaks to the strength and uniqueness of our innovation,” said Povl Verder, CEO. “We are addressing a high impact clinical problem with a solution that has no precedent and no direct competitors. Our rapid lung maturity test, the first of its kind, is currently under FDA review and is poised to transform respiratory care for premature infants worldwide. In parallel, our second product, a diagnostic that delivers rapid assessments of lung health in adult ICU patients, was recently validated in a European study.”
As Minneapolis, MN continues to attract and foster leading healthcare innovators, this recognition places SIME Diagnostics firmly among the companies shaping the future of medicine.
About SIME Diagnostics
SIME Diagnostics develops AI-powered medical diagnostics platforms designed for use in acute and intensive care settings. The company’s technology leverages machine learning and proprietary hardware to enable rapid, point-of-care testing for respiratory diseases. More information on the company can be found by visiting http://www.simedx.com or following SIME Diagnostics on LinkedIn.
